SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Shilpa Medicare

BSE: 530549|NSE: SHILPAMED|ISIN: INE790G01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 23, 16:01
543.55
-15.65 (-2.8%)
VOLUME 6,794
LIVE
NSE
Sep 23, 15:46
542.45
-16.75 (-3%)
VOLUME 59,349
Announcements on Shilpa

8th-Sep-2016 12:13Source: BSE

Shilpa- Fixes Book Closure for AGM

Shilpa Medicare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2016 to September 29, 2016 (both days inclusive) for the p...

27th-Aug-2016 15:02Source: BSE

Shilpa- Resignation of CFO & Company Secretary & Compliance Officer

Shilpa Medicare Ltd has informed BSE that :

1. Mr. Nihalchand Bhandari Chief Financial Officer of the Company has resigned from the services of the Company w.e.f. August 26, 2016.

2. Ms....

27th-Aug-2016 14:56Source: BSE

Shilpa- Revised Financial Results for June 30, 2016

With reference to the earlier Announcement dated August 26, 2016 regarding Financial Results for June 30, 2016, Shilpa Medicare Ltd has informed BSE that there is a typographical error occured in th...

26th-Aug-2016 14:48Source: NSE

Shilpa Medicare Limited

Shilpa Medicare Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.

26th-Aug-2016 14:46Source: BSE

Shilpa- Standalone Financial Results, Limited Review Report for June 30, 2016

Shilpa Medicare Ltd has informed BSE about :

1. Standalone Financial Results for the period ended June 30, 2016

2. Standalone Limited Review for the period ended June 30, 2016

17th-Aug-2016 14:08Source: BSE

Shilpa- Board Meeting Intimation for Results & Closure of Trading Window

Shilpa Medicare Ltd has informed BSE that a meeting of Board of Directors will be held on August 26, 2016, inter alia, to consider the un-audited financial results for the period and quarter ended Jun...

26th-Jul-2016 13:09Source: BSE

Shilpa- Updates

Shilpa Medicare Ltd has informed BSE that the Company had an audit conducted by the United States Food & Drug Administration (USFDA) at the SEZ Formulations facility situated at Jadcherla, near Hydera...

16th-Jul-2016 14:47Source: BSE

Shilpa- Shareholding for the Period Ended June 30, 2016

Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

9th-Jul-2016 14:56Source: BSE

Shilpa- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Shilpa Medicare Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing ...

4th-Jul-2016 18:10Source: BSE

Shilpa- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Tano Mauritius India FVCI II has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

1 2 3 4 5 Next >>
Quick Links for Shilpa Medicare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.